Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

BMC Cancer. 2019 Mar 21;19(1):257. doi: 10.1186/s12885-019-5458-y.

Wenxing Chen^{1

2}, Yanhong Pan¹, Siliang Wang¹, Yuping Liu¹, Guangying Chen³, Liang Zhou¹, Chao Zhang⁴, Wenting Ni¹, Aiyun Wang¹, Yin Lu^{5

6}, Shile Huang⁷

¹ School of Pharmacy, Nanjing University of Chinese Medicine, NO.138, Xianlin Avenue, Nanjing, 210023, Jiangsu Province, China.
² Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, Jiangsu Province, China.
³ College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou, 571158, China.
⁴ Louisiana State University Health Sciences Center, Shreveport, LA, USA.
⁵ School of Pharmacy, Nanjing University of Chinese Medicine, NO.138, Xianlin Avenue, Nanjing, 210023, Jiangsu Province, China. luyingreen@126.com.
⁶ Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, Jiangsu Province, China. luyingreen@126.com.
⁷ Louisiana State University Health Sciences Center, Shreveport, LA, USA. shuan1@lsuhsc.edu.

Abstract

Following publication of the original article [1], the author noticed the following errors in the article.